Costs and benefits associated with diabetes education a review of the literature

Diabetes Educator

Volumn 35, Issue 1, 2009, Pages 72-96

  Boren, Suzanne A ^a,b   Fitzner, Karen A ^c   Panhalkar, Pallavi S ^b   Specker, James E ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c American Association of Diabetes Educators   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; HEALTH CARE POLICY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEALTH POLICY; HUMANS; PATIENT EDUCATION AS TOPIC;

EID: 60049087100     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721708326774     Document Type: Article

References (39)

1. Schoen C., Guterman S., Shih A., et al. Bending the curve: options for achieving savings and improving value in U.S. health spending, The Commonwealth Fund, December 2007. http://www.commonwealthfund.org/publications/publications- show.htm?doc-id=620087. Accessed January 29, 2008.
2. Anderson G. Chronic conditions: making the case for ongoing care. Johns Hopkins University. November 2007. http://www.fightchronicdisease.com/news/pfcd/ documents/ChronicCareChartbook-FINAL.pdf. Accessed January 29, 2008.
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008 ; 31: 1-20.
4. DeVol R., Bedroussian A., Charuworn A., et al. An unhealthy America: the economic burden of chronic disease-charting a new course to save lives and increase productivity and economic growth. Milken Institute. October 2007. http://www.milkeninstitute.org/pdf/chronic-disease-report.pdf. Accessed January 29, 2008.
5. American Association of Diabetes Educators. About diabetes education. http://www.diabeteseducator.org/DiabetesEducation. Accessed February 5, 2008.
6. Norris SL, Nichols PL, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes: a systematic review. Am J Prev Med. 2002 ; 22 (suppl): 15-38.
7. Norris SL, Lau J., Smith SJ, Schmidt CH, Engelgau MM Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002 ; 25: 1159-1171.
8. Salber PR How managed care organizations contribute to improved diabetes outcomes. Am J Managed Care. 2008 ; 14: 9-12.
9. Gary TL, Genkinger JM, Guallar E., Peyrot M., Brancati FL Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ. 2003 ; 29: 488-501.
10. Balamurugan A., Ohsfeldt R., Hughes T., Phillips M. Diabetes self-management education program for Medicaid recipients: a continuous quality improvement process. Diabetes Educ. 2006 ; 32: 893-900.
11. Berg GD, Wadhwa S. Diabetes disease management in a community-based setting. Manag Care. 2002 ; 11: 45-50.
12. Burton WN, Connerty CM Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med. 1998 ; 40: 702-706.
13. Chase HP, Pearson JA, Wightman C., Roberts MD, Oderberg AD, Garg SK Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care. 2003 ; 26: 1475-1479.
14. Christensen NK, Williams P., Pfister R. Cost savings and clinical effectiveness of an extension service diabetes program. Diabetes Spectrum. 2004 ; 17: 171-175.
15. Cranor CW, Bunting BA, Christensen DB The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. JAm Pharm Assoc. 2003 ; 43: 173-184.
16. De Weerdt, Visser AP, Kok GJ, van der Veen EA Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life and cost of therapy. Diabetes Med. 1991 ; 8: 338-345.
17. Diabetes cost savings legislation would save millions for Ohio insurance industry, business, and taxpayers in productivity, emergency room visits, and hospital stays. October 4, 2005 [cited January 7, 2008 ]. http://www.diabetes. org/uedocuments/10.4.05DCRA.pdf.
18. Eddy DM, Schlessinger L., Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005 ; 143: 251-264.
19. Fries JF, McShane D. Reducing need and demand for medical services in high-risk persons: a health education approach. West J Med. 1998 ; 169: 201-207.
20. Garrett DG, Bluml BM Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005 ; 45: 130-137.
21. Gilmer TP, O'Connor PJ, Manning WG, Rush WA The cost to health plans of poor glycemic control. Diabetes Care. 1997 ; 20: 1847-1853.
22. Herman WH, Brandle M., Zhang P., et al. Diabetes Prevention Program Research Group: costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003 ; 26: 36-47.
23. Herman WH, Brandle M., Zhang P., et al. Diabetes Prevention Program Research Group: within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003 ; 26: 2518-2523.
24. Katon W., Unutzer J., Fan M., et al. Cost effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care. 2006 ; 29: 265-270.
25. Keers JC, Groen H., Sluiter WJ, Bouma J., Links TP Costs and benefits of a multidisciplinary intensive diabetes education program. J Eval Clin Pract. 2005 ; 11: 293-303.
26. Klonoff DC, Schwartz DM An economic analysis of interventions for diabetes. Diabetes Care. 2000 ; 23: 390-404.
27. Knowler WC, Barrett-Connor E., Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 ; 346: 393-403.
28. Menzin J., Langley-Hawthorne C., Friedman M., Boulanger L., Cavanaugh R. Potential short-term economic benefits of improved glycemic control. Diabetes Care. 2001 ; 24: 51-55.
29. Ragucci KR, Fermo JD, Wessell AM, Chumney ECG. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy. 2005 ; 25: 1809-1816.
30. Rosenblum MS, Kane MP Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus. J Manag Care Pharm. 2003 ; 9: 309-316.
31. Rubin RJ, Dietrich KA, Hawk AD Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endocrinol Metab. 1998 ; 83: 2635-2642.
32. Shetty S., Secnik K., Oglesby AK Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm. 2005 ; 11: 559-564.
33. Sidorov J., Shull R., Tomcavage J., Girolami S., Lawton N., Harris R. Does diabetes disease management save money and improve outcomes ? Diabetes Care. 2002 ; 25: 684-689.
34. Testa MA, Simonson DC Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998 ; 280: 1490-1496.
35. Wagner EH, Sandhu N., Newton KM, McCulloch DK, Ramsey SD, Grothaus LC Effect of improved glycemic control on health care costs and utilization. JAMA. 2001 ; 285: 182-189.
36. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002 ; 287: 2542-2551.
37. Ozminkowski RJ, Goetzel RZ, Smith MW, Cantor RI, Shaughnessy A., Harrison M. The impact of the Citibank, NA, health management program on changes in employee health risks over time. J Occup Environ Med. 2000 ; 42: 502-511.
38. Aldana SG Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promotion. 2001 ; 15: 296-320.
39. Department of Health and Human Services, Health Care Financing Administration. Federal Register, Part II; 42 CFR Parts 410, 414, 424, 480 and 498. Friday, December 29, 2000.